Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

CNTA

Centessa Pharmaceuticals plc ADR

May 29 • 04:00PM ET

39.76

-0.05 -0.13 %

Healthcare • Biotechnology • United Kingdom • Mid • NASD

Peers: BMRN RYTM APGE KRYS KYMR NUVL AXSM MDGL VKTX NBIX

| Held by: IBB SPDW FFSM ONEQ BBC ISCF MRGR IBBQ IBRN BIB

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.77	Insider Own	29.35%	Shs Outstand	154.73M	Perf Week	-0.13%
Market Cap	6.15B	Forward P/E	-	EPS next Y	-1.80	Insider Trans	-0.86%	Shs Float	109.31M	Perf Month	0.79%
Enterprise Value	5.99B	PEG	-	EPS next Q	-0.41	Inst Own	70.86%	Short Float	2.26%	Perf Quarter	48.03%
Income	-250.69M	P/S	-	EPS this Y	-15.44%	Inst Trans	1.10%	Short Ratio	0.94	Perf Half Y	37.29%
Sales	0.00M	P/B	12.62	EPS next Y	-7.02%	ROA	-42.87%	Short Interest	2.47M	Perf YTD	58.98%
Book/sh	3.15	P/C	22.24	EPS next 5Y	0.13%	ROE	-57.39%	52W High	40.26 -1.24%	Perf Year	204.21%
Cash/sh	1.79	P/FCF	-	EPS past 3/5Y	14.25% -130.75%	ROIC	-41.43%	52W Low	10.95 263.11%	Perf 3Y	820.37%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	0.24% 0.32%	Perf 5Y	82.80%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	1.57%	Oper. Margin	-	ATR (14)	0.24	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	9.53	Sales Y/Y TTM	-100.00%	Profit Margin	-	RSI (14)	70.66	Recom	2.67
Dividend Gr. 3/5Y	- -	Current Ratio	9.53	EPS Q/Q	-161.26%	SMA20	0.22%	Beta	1.12	Target Price	45.22
Payout	-	Debt/Eq	0.24	Sales Q/Q	-100.00%	SMA50	5.35%	Rel Volume	0.35	Prev Close	39.81
Employees	118	LT Debt/Eq	0.24	Earnings	May 18	SMA200	45.21%	Avg Volume	2.64M	Price	39.76
IPO	May 28, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	0.00% -	Trades		Volume	922,345	Change	-0.13%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)